Strain Tu 6239 was isolated from a soil sample collected in Brazil and determined as a new species of the genus Streptomyces. In the course of our HPLC-diode array screening program three metabolites were detected in the culture filtrate and mycelium extracts of strain Tu 6239. They were characterised as members of the macrolactam group, the new compound ripromycin (1), the previously described ikarugamycin (2) and a new derivative of it, ikarugamycin epoxide (3). They show antibiotic activities against Gram-positive bacteria and cytostatic effects to various human tumor cell lines.
Strain Tu 6239 was isolated from a soil sample collected in Sao Jose do Rio Preto, Brazil, during a program that was designed to the isolation of rare actinomycetes by heat and phenol treatment of the soils2). Chemotaxonomic methods and 165 rRNA analysis indicated that strain Tu 6239 may represent a new species of the genus Streptomyces. Strain Tu 6239 was included in our HPLC-diode array (HPLC-DAD) screening program to investigate the chemical diversity of secondary metabolites in culture filtrate and mycelium extracts by means of our HPLC-UV VisDatabase3). The UV-visible spectra and retention times of the resulting peaks were compared with those of more than 700 reference compounds, mostly antibiotics, stored in the database. Three dominant metabolites with retention times of 10.1, 11.8 and 14.6 minutes were produced by strain Tu 6239 ( Fig. 1) showing a high conformity in their UV-visible spectra to maltophilin, a macrolactam antibiotic produced by Stenotrophomonas maltophilia4), but differed significantly in their retention times.
This report deals with the taxonomy of the producing strain, fermentation, isolation, physico-chemical properties, and biological activities of the isolated metabolites.
Investigations on their chemical structures and biosynthesis are reported in a separate paper5). These results indicated that all three metabolites belong to the macrolactam group.
The metabolite with a retention time of 10. 
HPLC-DAD-Analysis
The chromatographic system consisted of a HP 1090M liquid chromatograph equipped with a diode-array detector and a HP Kayak XM 600 ChemStation using software revision A.08.03 (Agilent Technologies). Multiple wavelength monitoring was performed at 210, 230, 260, 280, 310, 360, 435 and 500nm; the spectrum range was from 200 to 600nm with a 2-nm step and a sampling rate of 640 milliseconds.
A 10-ml aliquot of the fermentation broth was centrifuged (10 minutes, 13,000g). The supernatant was adjusted to pH 5 and extracted with the same volume of EtOAc. The organic layer was concentrated to dryness and resuspended in 1ml MeOH. The mycelium pellet was extracted with 10ml MeOH, the extract was concentrated of the samples was injected onto a HPLC column (Maisch saturated iso-and anteiso-branched fatty acids. The spore mass colour of the aerial mycelium was gray and the spore chains were spiral with more than ten spores per chain.
( Table 1 . The antimicrobial spectra of the ripromycin (1), ikarugamycin (2) and ikarugamycin epoxide (3) were examined by an agar plate diffusion assay (Table 2) , and minimal inhibition concentrations was determined by the broth dilution method (Table 3) . Gram-negative bacteria were not sensitive to the compounds which exhibited moderate activities against Gram-positive bacteria and some fungi. 1, 2 and 3 showed no inhibitory activity against the green algae Chlorella fusca and Lemna minor (duckweed).
The compounds strongly inhibited the proliferation of 
